Cytomegalovirus reactivation in critically ill patients with acute respiratory distress syndrome
Publication date
2014-09-01
Authors
Ong, D.
Spitoni, C.
Klein Klouwenberg, P.
Verduyn Lunel, F.
Schultz, M.
Bonten, M.
Cremer, O.
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
No license information available
Abstract
Keywords
enzyme, antivirus agent, marker, DNA polymerase, DNA, Cytomegalovirus, human, critically ill patient, adult respiratory distress syndrome, society, intensive care, patient, risk, artificial ventilation, mortality, immunocompromised patient, hazard ratio, attributable risk, intensive care unit, blood, corticosteroid therapy, weaning, Netherlands, fatality, immunoassay, tertiary care center, sepsis, dependent variable, survival, virus, plasma, disease severity, virus load, drug megadose, polymerase chain reaction, transfusion, death, immune deficiency, APACHE, SDG 3 - Good Health and Well-being
Citation
Ong, D, Spitoni, C, Klein Klouwenberg, P, Verduyn Lunel, F, Schultz, M, Bonten, M & Cremer, O 2014, 'Cytomegalovirus reactivation in critically ill patients with acute respiratory distress syndrome', Intensive Care Medicine, vol. 40, no. 1 supplement, 0444, pp. S127. https://doi.org/10.1007/s00134-014-3451-0